Emcure subsidiary Gennova to transfer mRNA business to Immunoscript Life Science for ₹139 crore The Hindu Business Line 16:55 Sat, 11 Jul
Emcure Pharma divests mRNA business for Rs 139.5 crore to Immunoscript Life Science The Business Standard 08:42 Sat, 11 Jul
Gennova Biopharmaceuticals to transfer its mRNA business to Immunoscript Life Science The Business Standard 08:02 Sat, 11 Jul